Perrigo Co. plc buy melinda
Start price
16.08.17
/
50%
€71.18
Target price
12.09.17
€135.30
Performance (%)
13.26%
End price
12.09.17
€80.48
Summary
This prediction ended on 12.09.17 with a price of €80.48. The BUY prediction by melinda finished with a performance of 13.26%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Perrigo Co. plc | 0.698% | 0.698% | -53.756% | -69.119% |
| iShares Core DAX® | -1.741% | 5.979% | 8.977% | 49.858% |
| iShares Nasdaq 100 | 2.815% | 11.827% | 38.406% | 100.330% |
| iShares Nikkei 225® | -0.109% | 11.692% | 46.680% | 65.355% |
| iShares S&P 500 | 0.966% | 7.616% | 28.141% | 68.657% |
Comments by melinda for this prediction
In the thread Perrigo Co. plc diskutieren
Perrigo: FDA erteilt Zulassung für Generika AB bewertet
Perrigo Co. Plc engagiert sich in der Produktion von Over-the-Counter - Konsumgüter- und Pharma spezialisiert products.It arbeitet in den folgenden Bereichen: Consumer Healthcare (CHC), Consumer Healthcare Marke (BCH), verschreibungspflichtige Medikamente, und andere Sciences.The CHC Segment umfasst ...
(Vom Mitglied beendet)